Refat M. Nimer
Impact in
Papers in
-
- Metabolomics and Mass Spectrometry Studies 7
-
- COVID-19 Clinical Research Studies 4
- Co-authors
- Aladeen Alloubani (2 shared papers)Lina A. Dahabiyeh (9 shared papers)Anas M. Abdel Rahman (10 shared papers)Samer Swedan (4 shared papers)Omar F. Khabour (3 shared papers)Oliver Fiehn (2 shared papers)R. J. Dwayne Miller (1 shared paper)Hartmut Schlüter (1 shared paper)
- Journals
- Scientific Reports (3 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)International Journal of Molecular Sciences (1 paper)Current Cardiology Reviews (1 paper)Molecules (1 paper)
- Partner nations
- JordanSaudi ArabiaUnited States
In The Last Decade
Refat M. Nimer
22 papers receiving 345 citations
Peers
Comparison fields: 5 of 103
- Biological Psychiatry 8
- Clinical Biochemistry 15
- Neurology 18
- Spectroscopy 35
- Nephrology 15
Countries citing papers authored by Refat M. Nimer
This map shows the geographic impact of Refat M. Nimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Refat M. Nimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Refat M. Nimer more than expected).
Fields of papers citing papers by Refat M. Nimer
This network shows the impact of papers produced by Refat M. Nimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Refat M. Nimer. The network helps show where Refat M. Nimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Refat M. Nimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 170 | |
| 2 | 2014 | 43 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 17 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 11 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 8 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2025 | 1 |
About Refat M. Nimer
Refat M. Nimer is a scholar working on Molecular Biology, Infectious Diseases, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Neurology, having authored 24 papers that have together received 356 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (7 papers), COVID-19 Clinical Research Studies (4 papers), Cystic Fibrosis Research Advances (3 papers), Advanced Proteomics Techniques and Applications (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Vitamin C and Antioxidants Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Biological Psychiatry (8 citations), Clinical Biochemistry (15 citations), Neurology (18 citations), Spectroscopy (35 citations) and Nephrology (15 citations). Refat M. Nimer has collaborated with scholars based in Jordan, Saudi Arabia and United States. Frequent co-authors include Aladeen Alloubani, Lina A. Dahabiyeh, Anas M. Abdel Rahman, Samer Swedan, Omar F. Khabour, Oliver Fiehn, R. J. Dwayne Miller, Hartmut Schlüter, Marcus Wurlitzer and Marcel Kwiatkowski. Their work appears in journals such as Scientific Reports, Journal of Pharmaceutical and Biomedical Analysis, International Journal of Molecular Sciences, Current Cardiology Reviews and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.